IP Library › Granted Patent US 8,940,343
Granted Patent B2
US 8,940,343 · App. 13/637,464 · Granted Jan 27, 2015

Personal care composition

Inventors: Mohan Vijaykumar Chavan (Mumbai, IN); Deepak Ramachandra Mhasavade (Bangalore, IN); Ashish Anant Vaidya (Bangalore, IN)
Assignee: Conopco Inc.
A61Q17/04A61K8/35A61K8/498A61K8/894A61K8/97A61K2800/52A61Q5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,343
App. No.
13/637,464
Granted
Jan 27, 2015
Kind
B2
Abstract

The present invention relates to a personal care composition. More particularly the present invention relates to stabilization of UVA sunscreen dibenzoylmethane derivatives or even more particularly Parsol 1789™ (4-t-butyl-4′-methoxydibenzoylmethane) in personal care compositions. It is an object of the present invention to provide a personal care composition with relatively long photoprotection efficiency. It is another object of the present invention to stabilize Parsol 1789 by use of a natural substance or materials derived from plants. Surprisingly the present inventors have found that theaflavin or black tea extract having high levels of theaflavin, can act as a photostabilizer for dibenzoylmethane derivatives or Parsol-1789™.

Claims (17)

1. A personal care composition comprising:

i) a dibenzoylmethane derivative;

ii) 0.1 to 30% by weight theaflavin; and,

iii) a cosmetically acceptable base,

wherein the cosmetically acceptable base is a water-in-oil emulsion.

2. A composition as claimed in claim 1 comprising 0.3 to 10% theaflavin.

3. A composition as claimed in claim 1 wherein the dibenzoylmethane derivative is 4-t-butyl-4′-methoxydibenzoylmethane.

4. A composition as claimed in claim 2 comprising 0.1 to 10% dibenzoylmethane derivative by weight of the composition.

5. A composition as claimed in claim 1 wherein the theaflavin is selected from the group consisting of theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate, theaflavin-3 and 3′-digallate.

6. A composition as claimed in claim 1 comprising an aqueous extract of black tea of the Camellia sinensis species comprising theaflavin.

7. A composition as claimed in claim 6 wherein the aqueous extract of black tea comprises 2 to 15% w/w theaflavin.

8. A composition as claimed in claim 6 comprising 0.1 to 40% aqueous extract of black tea of the Camellia sinensis species.

9. A composition as claimed in claim 1 wherein the weight ratio of dibenzoylmethane derivative to theaflavin is from 10:1 to 1:5.

10. A composition as claimed in claim 1 further comprising para-methoxy cinnamic acid or its derivatives.

11. A composition as claimed in claim 1 comprising 0.1 to 10% w/w of para-methoxy cinnamic acid or its derivatives.

12. A composition as claimed in claim 1 wherein the water-in-oil emulsion comprises a crosslinked silicone elastomer blend.

13. A composition as claimed in claim 1 , wherein the composition provides superior chemical stability of the dibenzoylmethane derivative when exposed to ultraviolet radiation relative to the same composition but without the theaflavin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: CHAVAN, MOHAN VIJAYKUMAR; MHASAVADE, DEEPAK RAMACHANDRA; VAIDYA, ASHISH ANANT
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 029369/0969 →
Priority Claims (1)
IN 1145/MUM/2010 · Apr 6, 2010 · national
Continuity (1)
Related Publication 20130052148A1 · Feb 28, 2013